Adverse events48

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 48

Type	Event	Organ system	Group	Affected	At risk	Events
other	Injection site Pain	General disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	33	190	33
other	Injection site Pain	General disorders	CAM2038 q1w or q4w New to BPN Treatment	2	37	2
other	Injection SIte Swelling	General disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	25	190	25
other	Injection SIte Swelling	General disorders	CAM2038 q1w or q4w New to BPN Treatment	2	37	2
other	Injection site erythema	General disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	20	190	20
other	Injection site erythema	General disorders	CAM2038 q1w or q4w New to BPN Treatment	1	37	1
other	Nausea	Gastrointestinal disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	16	190	16
other	Nausea	Gastrointestinal disorders	CAM2038 q1w or q4w New to BPN Treatment	0	37	0
other	Headache	Nervous system disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	18	190	18
other	Headache	Nervous system disorders	CAM2038 q1w or q4w New to BPN Treatment	0	37	0
other	Vomiting	Gastrointestinal disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	12	190	12
other	Vomiting	Gastrointestinal disorders	CAM2038 q1w or q4w New to BPN Treatment	0	37	0
other	Nasopharyngitis	Infections and infestations	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	17	190	17
other	Nasopharyngitis	Infections and infestations	CAM2038 q1w or q4w New to BPN Treatment	1	37	1
other	Urinary tract infection	Infections and infestations	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	9	190	9
other	Urinary tract infection	Infections and infestations	CAM2038 q1w or q4w New to BPN Treatment	3	37	3
other	Diarrhoea	Gastrointestinal disorders	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	0	190	0
other	Diarrhoea	Gastrointestinal disorders	CAM2038 q1w or q4w New to BPN Treatment	2	37	2
serious	Cellulitis	Infections and infestations	CAM2038 q1w or q4w With Prior Exposure to SL BPN/NX	1	190	1
serious	Cellulitis	Infections and infestations	CAM2038 q1w or q4w New to BPN Treatment	0	37	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02672111/events

API reference For AI assistants

Adverse events48

Sources 3

Read this list from software.